Prevail Therapeutics logo
Healthcare & Life Sciences

Prevail Therapeutics

Prevail Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 1 tracked investor.

Activeseries-b
series-b
Stage
1
Investors

About Prevail Therapeutics

Prevail Therapeutics is a startup based in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

Prevail Therapeutics develops gene therapies aimed at treating neurodegenerative and rare diseases by addressing their genetic root causes, including Parkinson's disease linked to GBA1 genetic variants.

Explore Prevail Therapeutics's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in United States